- Biosimilar drugs2017 | First Faculty of Medicine, Third Faculty of Medicine
- Biosimilar drugs: what a rheumatologist should know2023 | First Faculty of Medicine
- Biosimilar treatment in paediatric gastroenterology - current view2022 | Second Faculty of Medicine
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update2017 | First Faculty of Medicine
- Age-related macular degeneration2022 | Third Faculty of Medicine
- Biosimilars in treating inflammatory rheumatic diseases2015 | First Faculty of Medicine
- Serum trough infliximab levels: A comparison of three different immunoassays for the monitoring of CT-P13 (infliximab) treatment in patients with inflammatory bowel disease2016 | First Faculty of Medicine
- Biosimilars in the treatment of inflammatory rheumatic diseases2022 | First Faculty of Medicine
- New guidelines for treatment of rheumatoid arthritis2018 | First Faculty of Medicine